Abstract
FOLLOWING the reports of Hunter and Greenwood1 and Reith and Tampion2, the chloramine T radioiodination procedure has been applied3,4 for labelling, with iodine-131, serum proteins from several animal species. High labelling efficiency (about 65 per cent) could be obtained provided oxidation was allowed to proceed for at least 30 min. The advantage of using a protein: chloramine T ratio of about 250 : 1 has been stressed3,4 in order to avoid even small damage to the proteins, undetectable by electrophoretic and immunological analyses but evident from metabolic behaviour in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hunter, W. M., and Greenwood, F. C., Nature, 194, 495 (1962). Greenwood, F. C., Hunter, W. M., and Glover, J. S., Biochem. J., 89, 114 (1963).
Reith, W. S., and Tampion, W., Nature, 197, 180 (1963).
Bocci, V., Boll. Soc. it. Biol. Sper., 40, 89 (1964).
Bocci, V., Intern. J. App. Rad. Isotopes (in the press).
Gornall, A. G., Bardawill, C. J., and David, M. M., J. Biol. Chem., 177, 751 (1949).
Bocci, V., Science Tools, 10 (to be published).
Smithies, O., Biochem. J., 71, 585 (1959).
Bocci, V., Nature, 203, 888 (1964).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BOCCI, V. Efficient Labelling of Tissue-soluble Proteins with Iodine-131 using Chloramine T. Nature 203, 985–986 (1964). https://doi.org/10.1038/203985a0
Published:
Issue date:
DOI: https://doi.org/10.1038/203985a0
This article is cited by
-
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
Journal of Nanobiotechnology (2022)
-
Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer
Nanoscale Research Letters (2019)


